Patent · US Active

Vaccine against streptococcal infections based on recombinant proteins

US9795664B2 · kind B2 · utility

0Cited by

1References

24Claims

0Family size

Assignee

INTERVACC AB · SE

Inventors

Bengt Guss · Uppsala, SE
Jan-Ingmar Flock · Bromma, SE
Lars Frykberg · Storvreta, SE
Margareta Flock · Bromma, SE

Key dates

Filing date	Dec 4, 2015
Grant date	Oct 24, 2017
Priority date	—
Expiry date	Dec 4, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/552
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An antigenic composition comprises several antigenic components derived from antigens of Streptococcus equi subsp. equi or subsp. zooepidemicus, wherein at least one component is a fusion protein or polypeptide compromising two or more such antigens or fragments thereof. The antigenic composition may be used for immunization of mammals against S. equi subsp. equi and/or subsp. zooepidemicus. A vaccine composition comprising the antigenic composition as immunizing component is also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.